High Court bars Glenmark from making anti-diabetes drugs
India | March 20, 2015 20:16 ISTNew Delhi: The Delhi High Court today restrained Indian firm Glenmark Pharmaceuticals from manufacturing, marketing or selling its anti-diabetes drugs Zita and Zita-Met, saying it has "prima facie" infringed the patent of US drug major